Treace Medical Concepts, Inc.
TMCI · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $426,188 | $370,481 | $525,730 | $463,814 |
| - Cash | $7,686 | $8,052 | $13,372 | $11,350 |
| + Debt | $12,930 | $70,094 | $69,364 | $69,653 |
| Enterprise Value | $431,432 | $432,523 | $581,722 | $522,117 |
| Revenue | $50,214 | $47,387 | $52,570 | $68,708 |
| % Growth | 6% | -9.9% | -23.5% | – |
| Gross Profit | $39,706 | $37,752 | $41,893 | $55,477 |
| % Margin | 79.1% | 79.7% | 79.7% | 80.7% |
| EBITDA | -$12,172 | -$13,501 | -$12,150 | $3,050 |
| % Margin | -24.2% | -28.5% | -23.1% | 4.4% |
| Net Income | -$16,288 | -$17,398 | -$15,922 | -$501 |
| % Margin | -32.4% | -36.7% | -30.3% | -0.7% |
| EPS Diluted | -0.26 | -0.28 | -0.25 | -0.008 |
| % Growth | 7.1% | -12% | -3,025% | – |
| Operating Cash Flow | -$9,092 | -$3,050 | $4,198 | -$4,207 |
| Capital Expenditures | -$2,809 | -$4,767 | -$3,543 | -$3,074 |
| Free Cash Flow | -$11,901 | -$7,817 | $655 | -$7,281 |